UK's NICE gives Roche drug green light for bladder cancer

loading...


UK’s NICE gives Roche drug green light for bladder cancer
LONDON (Reuters) – Britain’s healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche’s immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...